Loading the security overview…
Where the tokens are
Standardised from the company’s filings, newest period first, labelled with the company’s own fiscal calendar. A line the company does not report is left off rather than shown as zero; margins and free cash flow are worked out here, and only where every input is present.
| Line item | Q2 FY262026-06-30 | Q1 FY262026-03-31 | Q4 FY252025-12-31 | Q3 FY252025-09-30 | Q2 FY252025-06-30 | Q1 FY252025-03-31 | Q4 FY242024-12-31 | Q3 FY242024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $40.87B | $39.65B | $32.38B | $32.25B | $32.39B | $32.11B | $28.92B | $29.05B |
| Cost of revenue | $35.37B | $33.71B | $28.72B | $27.99B | $27.57B | $26.54B | $25.38B | $25.12B |
| Gross profit | $5.50B | $5.94B | $3.66B | $4.26B | $4.82B | $5.58B | $3.54B | $3.93B |
| Gross margin | 13.5% | 15.0% | 11.3% | 13.2% | 14.9% | 17.4% | 12.2% | 13.5% |
| Selling, general and administrative | $3.98B | $4.02B | $4.44B | $4.09B | $3.55B | $3.38B | $4.17B | $3.34B |
| Operating expenses | $39.51B | $37.89B | $33.32B | $32.25B | $31.29B | $30.10B | $29.76B | $28.67B |
| Operating income | $1.36B | $1.75B | −$944.00M | −$1.00M | $1.10B | $2.01B | −$840.00M | $385.00M |
| Operating margin | 3.3% | 4.4% | -2.9% | -0.0% | 3.4% | 6.3% | -2.9% | 1.3% |
| EBITDA | $1.55B | $1.95B | −$750.00M | $203.00M | $1.31B | $2.23B | −$600.00M | $628.00M |
| Interest expense | −$197.00M | −$193.00M | −$146.00M | −$168.00M | −$157.00M | −$160.00M | −$164.00M | −$169.00M |
| Income before taxes | $952.00M | $1.60B | −$1.01B | $134.00M | $741.00M | $1.69B | −$862.00M | $651.00M |
| Income taxes | $238.00M | $395.00M | −$249.00M | −$86.00M | $179.00M | $406.00M | −$216.00M | $155.00M |
| Net income | $693.00M | $1.18B | −$776.00M | $194.00M | $543.00M | $1.24B | −$683.00M | $480.00M |
| Net margin | 1.7% | 3.0% | -2.4% | 0.6% | 1.7% | 3.9% | -2.4% | 1.7% |
| EPS, basic | $5.78 | $9.85 | −$6.61 | $1.62 | $4.52 | $10.31 | −$5.75 | $3.99 |
| EPS, diluted | $5.73 | $9.83 | −$6.58 | $1.62 | $4.51 | $10.30 | −$5.74 | $3.98 |
| Diluted shares | 121.14M | 120.65M | 120.97M | 120.75M | 120.75M | 120.84M | 120.78M | 120.76M |
Figures describe Humana shares, not any token. As of Jul 29, 2026, from Massive's standardised financials. The company reports these figures; a token's issuer holds the shares and reports nothing of its own here.